Cargando…
ALDH3B1 Is an Independent Prognostic Biomarker of Lung Adenocarcinoma
BACKGROUND: Lung cancer is the leading cause of cancer-related death, and adenocarcinoma is the most common type of lung cancer. Although emerging evidence implicates the role of several aldehyde dehydrogenases in cancer progression, the expression and clinical significance of aldehyde dehydrogenase...
Autores principales: | Sun, Hongmei, Zhang, Mingying, Li, Li, Huang, Zongwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412899/ https://www.ncbi.nlm.nih.gov/pubmed/32744175 http://dx.doi.org/10.1177/1533033820946018 |
Ejemplares similares
-
Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma
por: Zheng, Xiangyu, et al.
Publicado: (2020) -
Aldehyde dehydrogenase 1 (ALDH1) immunostaining in axillary lymph node metastases is an independent prognostic factor in ALDH1-positive breast cancer
por: Guan, Xin, et al.
Publicado: (2021) -
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis
por: Yin, Zhenhua, et al.
Publicado: (2020) -
The prognostic roles of ALDH1 isoenzymes in gastric cancer
por: Li, Kai, et al.
Publicado: (2016) -
Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker
por: Zou, Kang, et al.
Publicado: (2023)